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Sendai viruses (SeV) derived from persistent infection have a capacity to interfere with co-infected wild-type virus. Here we showed that
interference was also caused by the laboratory strains Z and Nagoya. The leader mutations A20U and A24U related to viral adaptation from mice to
chicken eggs significantly affected the capacity for viral interference, especially through genome amplification. Furthermore, recombinant SeV
that possessed the mutations A34G and G47A, which are commonly found in the leader sequence of persistent infection-derived SeV strains, had an
increased capacity for interference. Viral replication of human parainfluenza viruses 1, 2, and 3, but not the mumps virus or Newcastle disease
virus, was suppressed by co-infection of a persistent infection-derived SeV strain, suggesting suppression of closely related human
paramyxoviruses. These results indicate that homologous interference is partly dependent on the promoter sequence and further suggest
involvement of promoter activity for genome amplification related to host factors in viral interference.
© 2007 Elsevier Inc. All rights reserved.Keywords: Paramyxovirus; Sendai virus; Persistent infection; Homologous interference; Reverse genetics; Leader sequenceIntroduction
Sendai virus (SeV), also designated as hemagglutinating virus
of Japan (HVJ), belongs to the family Paramyxoviridae, which
includesmany human and animal pathogens. SeVis an enveloped
virus containing a single-stranded negative-sense RNA genome,
which is composed of six genes encoding structural essential
proteins, including N (nucleocapsid), P (phospho-), M (matrix),
F (fusion), HN (hemagglutinin-neuraminidase), and L (large)
proteins, and also non-essential V, W, and C proteins (Lamb and
Parks, 2006). At both ends of the genome are the leader and trailer
sequences, the promoters for transcription and replication.
Persistent infection by SeV has been widely investigated.
SeV-infected cultured cells can be maintained by serial passage,
undergoing occasional massive cell death (crisis) in the early
stage of cell passage and leading to a stable persistent infection
in the subsequent late stage. At least two factors have been⁎ Corresponding author. Fax: +81 82 257 5159.
E-mail address: tsaka@hiroshima-u.ac.jp (T. Sakaguchi).
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doi:10.1016/j.virol.2007.10.026reported to establish and maintain persistent infection: defective
interfering (DI) genomes and temperature-sensitive SeV (Roux
and Holland, 1979; Yoshida et al., 1982).
Virus strains derived from an SeV carrier culture are often
temperature-sensitive and can easily establish a persistent in-
fection in fresh cells without involvement of the DI genomes
(Yoshida et al., 1982); thus, the viruses may have mutations that
allow minimum cytopathogenicity and persistence in cells. The
persistent infection-derived SeV usually interferes with the
growth of parental wild-type SeV; mixed infection of the wild-
type virus and the persistent infection-derived virus causes
suppression of protein synthesis of the wild-type virus and
reduces wild-type virus growth. This “homologous interfer-
ence” is thought to be an important factor for supporting the
maintenance of stable persistent infection (Yoshida et al., 1982).
We previously reported homologous interference with a field
SeV isolate, the Hamamatsu strain, by co-infection of SeV-pi
(originally called HVJ-pi), an SeV strain derived from a carrier
culture, in BHK-21 cells (Yoshida et al., 1982) and in mouse
lungs (Kiyotani et al., 1990). SeV-pi was shown to have
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infection of SeV possibly via homologous interference as well
as induced immunity (Kiyotani et al., 1990). However, the
mechanism of interference is not clearly understood.
In the present study, we showed that SeV derived from
conventional laboratory strains, Nagoya and Z strains, in addition
to strains derived from persistent infection caused homologous
interference with the Hamamatsu strain. Furthermore, compari-
son of the leader sequence and reverse genetics demonstrated that
the leader sequencewas involved in the homologous interference.
Results
Suppression of protein synthesis of SeV-H by co-infection of the
laboratory strain SeV-N
CV1 cells were infected with SeV at an input m.o.i. of 10.
After 8 h, proteins were metabolically labeled with [35S]cys-
teine–methionine for 30 min and analyzed by immunopreci-
pitation and SDS-PAGE.When CV1 cells were co-infected with
the Hamamatsu strain (SeV-H) and the Nagoya strain (SeV-N),
protein synthesis of SeV-H was suppressed as revealed byFig. 1. Suppression of protein synthesis of SeV-H by co-infection of SeV laboratory st
and SeV-H (B), and SeV-N and SeV-Z (C), each at an input m.o.i. of 10, and with SeV
8 h. Proteins were then pulse-labeled with [35S]cysteine–methionine for 30 min,
and autoradiography. The percent composition of the P protein in a mixed infection is
m.o.i. of 10 each and pulse-labeled as described above at various time points after in
cells were infected with SeV-N and SeV-H, SeV-N alone, or SeV-H alone at an m.o.i.
The viral genomes released in the medium were amplified by RT-PCR using com
nucleotides 12,170–12,182 in the L gene is shown. Arrowheads and underlines shocomparison with the P protein, whose migration in SDS-PAGE
varied between SeV-N and SeV-H (Fig. 1A). About 93% of the
P protein was derived from SeV-N and only about 7% was
derived from SeV-H (Fig. 1A), indicating that the proteins
derived from SeV-N were dominant.
Co-infection of SeV-H with the Z strain (SeV-Z), a laboratory
strain, also reduced the proportion of P protein derived from SeV-
H to ca. 3% (Fig. 1B), indicating that SeV-Z as well as SeV-N has
the capacity for interference with SeV-H protein synthesis. In
contrast, amixed infection of SeV-N and SeV-Z did not show such
suppression of protein synthesis as revealed by comparison of the
N protein whose migration is distinct between the two strains
(Fig. 1C). These results indicate that proein synthesis of SeV-H is
easily suppressed by homologous SeV laboratory strains.
We performed a co-infection experiment with varying m.o.i.
of SeV-N (m.o.i.=0, 1, 2, 5, 10, 20, 30). The suppression of
SeV-H (fixed to m.o.i. of 10) was dependent on the m.o.i. of
SeV-N, showing replicative advantage of SeV-N over SeV-H
(Fig. 1D). Protein labeling at various time points after infection
(Fig. 1E) showed that the amounts of the P protein at 3 h post-
infection (p.i.). were almost the same and that the P protein
derived from SeV-N was dominant at 6 h p.i. or later. Theserains. Monolayers of CV1 cells were infected with SeV-N and SeV-H (A), SeV-Z
-H (m.o.i.=10) and SeV-N (m.o.i.=1–30) (D) and further incubated at 37 °C for
immunoprecipitated with anti-SeV rabbit serum, and analyzed by SDS-PAGE
shown below the figure. (E) CV1 cells were infected with SeV-N and SeV-H at an
fection as indicated. (F) Genome amplification of released progeny virus. CV1
of 10 each, and the medium was collected at indicated time points after infection.
mon primers and directly sequenced. An electrogram for the sequence of the
w varying nucleotides between SeV-N and SeV-H.
Fig. 2. Multiple nucleotide sequence alignment of the leader (A) and trailer (B) regions of SeV. Nucleotides are shown in comparison to the reference strain, SeV-N,
and identity is indicated by dashes. The transcription start sequence of the N gene and the transcription termination sequence of the L gene are underlined. Common
mutations among the viruses isolated from SeV-cell carrier cultures are boxed, and amino acids of the field isolates SeV-H and SeV-O affected by passage in
embryonated chicken eggs are shadowed.
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quent secondary transcription, but not primary transcription,
were suppressed in the case of co-infection with SeV-N.Fig. 3. Effects of SeV-HUU on SeV-N protein synthesis and genome amplification. (A
m.o.i. of 10 each and further incubated at 37 °C for 8 h. Proteins were analyzed as des
HUU at an m.o.i. of 10 each and pulse-labeled as described above at various time po
virus. CV1 cells were infected with SeV-N and SeV-HUU, SeV-N alone, or SeV-HU
points after infection. The viral genomes released in the medium were amplified by R
of Fig. 1. Arrowheads and underlines show varying nucleotides between SeV-N and S
the SeV strains at an input m.o.i. of infection and a part of the mediumwas collected at
plotted in the graph, and the error bar indicates standard deviation.To investigate genome amplification in co-infection of SeV-
H and SeV-N, cells were infected with both of the viruses at an
m.o.i. of 10 each, and culture medium from the infected cells) Monolayers of CV1 cells were infected with SeV-N and SeV-HUU at an input
cribed in the legend of Fig. 1. (B) CV1 cells were infected with SeV-N and SeV-
ints after infection as indicated. (C) Genome amplification of released progeny
U alone at an m.o.i. of 10 each, and the medium was collected at indicated time
T-PCR using common primers and directly sequenced as described in the legend
eV-HUU. (D) Virus growth of SeV strains. CV1 cells were infected with one of
indicated time points after infection. The mean infectivity of triplicate samples is
Fig. 4. Effect of mutations found in viruses from persistent infection on protein
synthesis of SeV-H. Monolayers of CV1 cells were infected with SeV-ZLN and
SeV-H (A) and with SeV-ZLNpi and SeV-H (B) each at an m.o.i. of 10 and
protein synthesis was analyzed as described in the legend of Fig. 1. (C)
Radioactivity of the P proteins derived from SeV-H-based virus or SeV-Z-based
virus was quantified by an image analyzer, and ratios are plotted in the graph.
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the medium and a region of viral genomic RNA was amplified
by reverse-transcription and polymerase chain reaction (RT-
PCR) using primers that annealed to the genomes of both
viruses. Direct sequencing of the DNA fragments showed that
the genome of SeV-H was dominant at 9 h p.i. but that the
genome of SeV-N predominated over that of SeV-H at 12 and
24 h p.i. (Fig. 1F). These results suggest that not only protein
synthesis but also genome replication of SeV-N is dominant
over that of SeV-H in mixed infection.
Nucleotide sequence analysis of the leader and trailer
sequences of SeV strains
Since interference with protein synthesis suggests selective
replication of one genome over the other, it was expected that
promoter regions of the viruses would show some differences.
Thus, we analyzed the nucleotide sequences of the leader and
trailer regions of SeVs (Fig. 2).
Leader and trailer sequences of SeVs derived from persistent
infection, SeV-pi, SeV-pi (H), and SeV-cl.151, and their paren-
tal strain, SeV-N, were determined and their alignment is shown
in Fig. 3. The promoter regions were highly conserved among
the strains. However, SeV-pi, SeV-pi (H), and SeV-cl.151 had
two common nucleotide substitutions, A34G and G47A, that
were distinct from the parent strain, and SeV-pi had an additio-
nal mutation, U29A. There was no sequence variation in the
trailer region between the Nagoya strain and its descendants
isolated from persistent infection.
SeV-N had a leader sequence identical to that of SeV-H
except at positions 20 and 24. Nucleotides 20A and 24A have
been found in SeV strains freshly isolated from an epidemic,
such as SeV-H (Sakaguchi et al., 1994) and the Ohita strain
(SeV-O; Itoh et al., 1997). Nucleotides 20 and 24 of SeV-H have
been shown to change from A to U by 15 passages in anunnatural host, embryonated chicken eggs (Fujii et al., 2002b),
and these mutations alone were sufficient to cause disturbance
of virus growth and attenuation of virulence in mice (Fujii et al.,
2002a). The 20U and 24U nucleotides of SeV-N as well as those
of SeV-Z are consistent with their long passage history in
embryonated eggs (Matsumoto et al., 1961).
The 20U and 24U mutations in the leader sequence control
homologous interference
The sequence comparison presented in Fig. 2 shows that SeV-
N and SeV-H have identical leader sequences except at positions
20 and 24. We next employed SeV-HUU, which was generated
from cDNAand contained the 20U and 24Umutations in the SeV-
H backbone (Fujii et al., 2002a). Thus, SeV-HUU and SeV-N
have the same leader sequences, while the other parts of the
genomes are derived from SeV-H and SeV-N, respectively. Co-
infection of SeV-N and SeV-HUU resulted in larger amounts of
the P protein derived from SeV-HUU (35.4%±0.5%, mean±
standard deviation, n=3; Fig. 3A) when compared to co-infection
of SeV-N and SeV-H (Fig. 1A), indicating that the leader se-
quence affects interference with protein synthesis.
We also employed E15cl2 instead of SeV-HUU. E15cl2 is a
mutant obtained from SeV-H after 15 passages in embryonated
eggs and also possesses the same leader sequence as that of
SeV-HUU with an additional two amino acid substitutions in
the L protein (Fujii et al., 2002b). The results obtained from co-
infection of E15cl2 and SeV-N were similar to those obtained
from co-infection of SeV-HUU and SeV-N (data not shown).
Protein pulse-labeling at various time points also showed
almost equivalent synthesis of P proteins derived from SeV-N and
SeV-HUU (Fig. 3B). Direct sequencing of the RT-PCR products
from the culture medium indicated that, unlike mixed infection of
SeV-N and SeV-H (Fig. 1F), replications of the genomes of the
two viruses were almost the same at 12 and 24 h p.i. (Fig. 3C).
This suggests that the 20U and 24U mutations affected genome
replication aswell as protein synthesis. Similar results for genome
amplification were obtained when cells were infected with SeV-N
and SeV-H (or SeV-HUU) at an m.o.i. of 0.01 and maintained in
the presence of trypsin for 5 days (data not shown).
The dominance of SeV-N over SeV-H may be due to a head
start of SeV-N over SeV-H. We thus investigated growth of each
virus in CV1 cells, especially at early time points (Fig. 3D). The
results showed that SeV-H and SeV-HUU replicated slightly
faster than did SeV-N. This is consistent with dominance of
SeV-H and SeV-HUU genomes at 9 h p.i. (Figs. 1F and 3C) and
indicates that dominance of SeV-N over SeV-H was not due to
early start of virus growth.
Mutations of persistent infection-derived viruses are involved
in interference with protein synthesis
We investigated the involvement of A34G and G47A muta-
tions, commonly found in the leader sequence of strains derived
from persistent infection, SeV-pi, SeV-pi (H) and SeV-cl.151
(Fig. 2), in interference with viral protein synthesis. We first
introduced the leader sequence of SeV-N into the genomic
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which was designated as SeV-ZLN. SeV-ZLN had the leader
sequence derived from the Nagoya strain, and the other parts
were from SeV-Z. We further generated SeV-ZLNpi, which had
the persistent infection-derived mutations A34G and G47A
based on the SeV-ZLN virus.
Recovery efficiencies of the mutant viruses were almost
equivalent to that of control SeV-Z (data not shown), and virus
infectivities after incubation in eggs at 32 °C for 3 days ranged
from 109 to 1010 CIU/ml, indicating comparable viral growth of
the mutant viruses in embryonated chicken eggs.
As shown in Fig. 4, when SeV-ZLNpi was used instead of
SeV-ZLN in a mixed infection with SeV-HUU, the proportion
of proteins derived from SeV-HUU decreased from ca. 40% to
ca. 17%. These result indicate that the mutations associated with
SeV persistent infection gave an advantage to protein synthesis
of SeV-ZLN, suggesting that the mutations slightly enhance
interference with protein synthesis. We could not detect a sig-Fig. 5. (A, B) Suppression of protein synthesis of paramyxoviruses by co-infection
HPIV-1, HPIV-2, or HPIV-3 (A) or with NDVor MuV (B) each at an m.o.i. of 2.5 wit
then pulse-labeled with 35S-methionine for 2 h, immunoprecipitated with rabbit an
Proteins of SeV-pi are indicated on the left side of panels. (C) Suppression of viral in
MK2 cells were infected with SeV-H, HPIV-1, HPIV-2, HPIV-3, NDV, MuV, or vesic
10). Cells were incubated at 32 °C for 24 h and infectivity in the mediumwas measure
pi is shown in the graph.nificant difference in the compositions of genomes released
from the infected cells after 24 h when using RT-PCR and
nucleotide sequencing, probably due to a relatively minor effect
of the mutation (data not shown).
The ratio of the P protein in SeV-ZLNpi increased compared
to that in SeV-ZLN in a mixed infection with SeV-H (Fig. 4C).
A similar tendency was observed when SeV-H was used instead
of SeV-HUU, although the P protein derived from SeV-H
showed an overall decrease (Fig. 4C). These results confirmed
the positive effect of the A34G and G47A mutations and the 20U
and 24U mutations in the leader sequence on competitive
protein synthesis in a mixed infection.
Interference with paramyxoviruses by co-infection with SeV-pi
We further investigated whether SeV-pi caused interference
with paramyxoviruses related to SeV. In mixed infection and
protein labeling, SeV-pi, which was infected at an input m.o.i.with SeV-pi. Monolayers of LLC-MK2 cells were infected with SeV-pi, SeV-H,
h or without SeV-pi (m.o.i. of 2.5) and incubated at 32 °C for 24 h. Proteins were
tiserum against each virus, and analyzed by SDS-PAGE and autoradiography.
fectivity of paramyxoviruses by co-infection with SeV-pi. Monolayers of LLC-
ular stomatitis virus (VSV) (m.o.i.=2.5) together with SeV-pi (m.o.i.=0, 2.5, or
d by a standard plaque assay. Percent infectivity compared with that without SeV-
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well as a control SeV-H, which was also infected at an m.o.i. of
2.5 (Fig. 5A). In contrast, SeV-pi did not suppress protein
synthesis of NDV and MuV (Fig. 5B).
Virus infectivity in the supernatant at 24 h after infection was
quantitated by a plaque assay in LLC-MK2 cells. Since SeV-pi
does not form any plaques in this condition, infectivity of the
counterpart virus could be measured. The results demonstrated
that virus infectivities of HPIV-1, HPIV-2, HPIV-3, and SeV-H
were significantly reduced when SeV-pi was co-infected
(Fig. 5C). The extent of the reduction was less than 1% when
SeV-pi was co-infected at an input m.o.i. of 10. In contrast,
infectivities of NDVand MuV were reduced by only half when
SeV-pi was co-infected even at an m.o.i. of 10 (Fig. 5C). Half
infectivities of NDVand MuV were also observed when SeV-pi
had been UV-irradiated (data not shown). Together with the
observations that SeV-pi did not suppress VSV at all (Fig. 5C),
this partial suppression may be due to competition in sialic acid
receptor binding.
These results demonstrate that SeV-pi suppressed virus
multiplication of co-infected HPIV-1, -2, and -3 but not that of
NDV and MuV and that this interference by SeV-pi affected
virus replication after virus attachment.
Co-infection of SeV-N suppressed protein synthesis of
HPIV-1, 2, and 3 as well as that of SeV-pi (data not shown).
The suppression of protein synthesis by SeV-N, however,
appears to be relatively weak compared to that of SeV-pi.
Furthermore, SeV-N did not reduce protein synthesis of NDVor
MuV (data not shown).
Discussion
We previously isolated an SeV from BHK-21 cells
persistently infected with SeV Nagoya strain that had been
maintained for over 10 years. The isolated virus, HVJ-pi, also
denoted as SeV-pi in this paper, caused no CPE when fresh
BHK-21 cells were infected with the virus, and the virus im-
mediately induced persistent infection in infected cells without
involvement of the DI genome (Yoshida et al., 1982). The virus
was thought to have acquired the ability to cause persistent
infection in cultured cells during long-term persistent infection.
On the other hand, SeV-pi has the capacity to interfere with
homologous SeV strains. When BHK-21 cells were infected
with SeV-pi and SeV-N both at an input m.o.i. of 10, protein
synthesis and growth of SeV-N were selectively suppressed, and
this interference by SeV-pi was observed only at the early stages
during the one-step growth of SeV-N (Yoshida et al., 1982).
Similarly, when LLC-MK2 cells were infected with SeV-pi and
SeV-H, protein synthesis and virus growth of SeV-H were
strongly suppressed, and when mice were infected with both of
the viruses simultaneously, the mice survived lethal infection
with the Hamamatsu strain, probably due to the effect of the
interference (Kiyotani et al., 1990). Interference was thought to
occur in the early step of virus replication after virus entry as
shown using a UV-irradiated virus. Viruses derived from
persistent infection, cl-151 and SeV-pi (H) (originally denoted
as ND ts Sendai and isolated from carrier cultures independentlyof SeV-pi; Yoshida et al., 1983), also had a capacity to interfere
with SeV-H (Takao et al., unpublished observation).
Homologous interference is thought to be important in the
maintenance of persistent infections (Yoshida et al., 1982). In
the early period of persistent infection, surviving cells are
unstable and massive cell death (crisis) occasionally occurs
during cell passage. However, persistent infection is maintained
steadily in the late period. Interference is thought to suppress
replication of the cell-toxic wild-type virus, thus preventing
crisis and/or emergence of a lytic virus by mutation.
The present study showed that SeV-N predominated over
SeV-H when co-infected. This dominance occurred not because
SeV-N had a faster growth rate than that of SeV-H but probably
because SeV-N suppressed protein synthesis of SeV-H.
Interference is therefore not necessarily associated with
persistent infection. We identified two mutations common to
viruses derived from persistent infection [SeV-pi, cl-151 and
SeV-pi (H)]. Using a reverse genetics approach, the mutations
were found to augment the capacity for interference in the
background of the Nagoya leader sequence-possessing SeV-Z.
Regarding the establishment of persistent infection, viruses
possessing only these leader mutations could not generate
immediate persistent infection (Shimazu et al., an unpublished
observation). In order to establish persistent infection, muta-
tions other than the leader mutations may be required. Recently,
a mutation in the polymerase L protein was shown to be
important for immediate establishment of persistent infection in
the SeV-pi strain (Nishio et al., 2004; Nishimura et al., 2007).
Furthermore, the leader mutations U20A and U24A
significantly affected interference with protein synthesis and
genome amplification. This is probably due to suppression of
the SeV-H promoter of anti-genome synthesis (namely, the
leader sequence) by SeV-N. These mutations, which are
generally found in SeV strains passaged in chicken eggs,
ameliorate virus replication in mouse lungs and pathogenicity in
mice in the case of SeV-H, suggesting that the leader interacts
with host-specific factors (Fujii et al., 2002a,b; Kiyotani et al.,
2001). The fact that the same mutations also affect interference
strongly suggests involvement of an interacting host factor.
There is the possibility that not only viral polymerase proteins
N, P, and L but also some host factors co-operate for the
initiation of anti-genome synthesis.
Interference by SeV-pi and SeV-N not only with SeV but also
with other paramyxoviruses was observed. Interference with
HPIV-1 and 3 was observed, but interference with NDV or
mumps virus was not detected. The former two are classified in
the same Respirovirus genus as SeV and the latter two are
classified in the distinct Avulavirus and Rubulavirus geni,
respectively; thus, paramyxoviruses closely related to SeV were
suppressed by co-infection with SeV-pi. Interference with
human parainfluenza virus type 2, which is classified in the
genus Rubulavirus, was also suppressed by SeV-pi. Interference
of these SeV-related human paramyxoviruses may also depend
on the viral leader sequences by competing for a common host
factor. Comparison of the leader sequences of these viruses did
not reveal a general rule for interference, since the leader
sequence was highly divergent.
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interference by SeV. Conventional laboratory strains, SeV-N
and SeV-Z, as well as SeV-pi had the capacity to interfere with
replication of SeV-H. Nucleotide sequencing of the leader
sequence and a reverse genetics approach revealed that
homologous interference is partly dependent on the promoter
sequence. The fact that leader mutations associated with
persistent infection and viral adaptation to distinct hosts
augmented the capacity for interference suggests an interaction
of viral RNA synthesis machinery with host factors for anti-
genome synthesis starting from the leader sequence.
Materials and methods
Viruses and cells
The SeV carrier culture was established by inoculating SeV
Nagoya strain into BHK-21 cells or HeLa cells and maintaining
survived cells for more than 500 generations over 10 years
(Yoshida et al., 1979, 1982, 1983). SeV-pi, also known as
HVJpi, and SeV-pi (H), also known as ND ts Sendai, were
isolated from BHK-21 cells and HeLa cells persistently infected
with SeV, respectively (Yoshida et al., 1982; 1983). SeV cl-151
is a plaque-purified clone from a SeV-BHK-21 carrier culture
established independently.
SeV laboratory strains, the Nagoya strain (SeV-N) and the Z
strain (SeV-Z), were described by Kiyotani et al. (1990) and
Kato et al. (1996), respectively. A field isolate of SeV, the
Hamamatsu strain (SeV-H), and its mutants SeV-HUU (denoted
in the previous paper as rSeV-H-20A24A) and E15cl2 were
described in Fujii et al. (2002a,b). SeVs were propagated in
embryonated chicken eggs, and infectivity was measured by an
immunofluorescent infectious focus assay and expressed as cell
infectious units (CIU)/ml (Kiyotani et al., 1990).
Human parainfluenza virus type 1, type 2 (Greer strain), and
type 3 (C243 strain) were propagated in LLC-MK2 cells.
Mumps virus (Miyahara strain) and Newcastle disease virus
(Miyadera strain) were propagated in HEp-2 cells and
embryonated chicken eggs, respectively. Vaccinia virus expres-
sing the T7 RNA polymerase, vTF7.3 (Fuerst et al., 1986), was
kindly provided by Bernard Moss (National Institute of Health,
USA) and propagated in CV1 cells.
LLC-MK2 cells and CV1 cells were grown in Eagle's
minimal essential medium (MEM) supplemented with 10%
fetal calf serum.
Nucleotide sequence determination of the 3′ and 5′ genome
ends of SeV strains
The 3′- and 5′-terminal regions of the viral genome were
amplified by the rapid amplification of cDNA ends (RACE)
system according to the manufacturer's protocol (Roche
Diagnostics, Indianapolis, IN). Briefly, the genomic or
antigenomic strand of viral RNA was reverse-transcribed with
a specific primer, and a poly A tract was attached to the 3′ end of
the synthesized DNA by the terminal deoxynucleotidyl
transferase. The tailed DNA was then amplified by PCR witha viral specific primer and the oligo dT-anchor primer from the
kit. The PCR product was directly sequenced using a BigDye
terminator Sequencing Kit and a 310 genetic analyzer (PE
Biosystems, Foster City, CA). The entire genomic sequences of
SeV-N and SeV-pi are available with DDBJ/EMBL/GenBank
accession numbers AB195968 and AB195967, respectively.
The leader and trailer sequences of cl-151 and SeV-pi (H) are
available with the accession numbers, AB249900, AB249901,
AB249902, and AB249903.
Recovery of SeV possessing mutations in the leader sequence
The pSeV(+) plasmid (Kato et al., 1996), which carries the
entire genomic cDNA of SeV-Z, was digested with BsiWI and
SphI. A BsiWI/SphI fragment of 616 nucleotides long contain-
ing the leader sequence was subcloned into a modified pGEM7
vector that had a BsiWI site in the multiple cloning site. Site-
directed mutagenesis was performed on the plasmid using the
QuickChange mutagenesis kit (Stratagene, La Jolla, CA, USA).
All of the mutants were screened by sequence analysis. The
mutated fragments were then returned to pSeV(+).
SeV was recovered from the recombinant plasmids as
described previously (Kato et al., 1996). Briefly, vTF-7.3-
infected LLC-MK2 cells were transfected with mutant pSeV(+)
together with pGEM-N, pGEM-P, and pGEM-L. Embryonated
chicken eggs were inoculated with the cell lysates and incubated
at 32 °C for 3 days.
Protein analysis by metabolic labeling and immunoprecipitation
Confluent monolayers of CV1 cells in a 35-mm dish were
infected with SeV at an m.o.i. of 10 and incubated for 8 h at
37 °C. The cells were then labeled with [35S]cysteine–
methionine (3.7 MBq/ml; GE Healthcare Bioscience) for
30 min in cysteine- and methionine-free MEM. Alternatively,
for viruses other than SeV, infected LLC-MK2 cells were
incubated for 24 h at 32 °C and labeled with [35S]methionine
(GE Healthcare Bioscience) for 2 h. The cells were then
solubilized in radioimmunoprecipitation assay buffer (10 mM
Tris–HCl, pH 7.4, 1% Triton X-100, 1% sodium deoxycholate,
0.1% SDS, 150 mM NaCl). Polypeptides were immunopreci-
pitated with either anti-SeV, anti-HPIV-1, anti-HPIV-2, anti-
HPIV-3, anti-NDV, or anti-VSV rabbit sera and analyzed by
SDS-PAGE as described previously (Kiyotani et al., 1990).
Autoradiograms were analyzed using a BAS2000 bioimaging
analyzer (Fuji, Tokyo, Japan).
Genome amplification
CV1 cells were infected with SeV strains at an input m.o.i. of
10 each and after an incubation period, RNAwas extracted from
the culture medium using the ISOGEN reagent according to the
manufacturer's protocol (Nippon Gene, Tokyo, Japan), and
reverse-transcribed with the primer 1(+), 5′-GAAGAGGATCT-
CAACCTGGC-3′, corresponding to the 11,673–11,692 region
in the L gene, and amplified by PCR using 1(+) and the
reverse primer 4(−), 5′-CTCCCCTGCTTCTTTGAGTG-3′,
71Y. Shimazu et al. / Virology 372 (2008) 64–71corresponding to the 12,517–12,536 region of the L gene. The
amplified DNA fragments were purified using agarose gel
electrophoresis and the nucleotide sequence was analyzed with
the reverse primer 2(+), 5′-GCTAGAAACACCAGACCCTT-
3′, by a 310 genetic analyzer as described above.
Growth curve
CV1 cells were infected with SeV strains at an input m.o.i. of
10 andmaintained inDMEM.A part of themediumwas collected
at indicated time post-infection (p.i.). Infectivity in the medium
was measured after trypsin treatment and plotted in the graph.
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